Skip to main content
News Archive

The ‘Dragon’ Targets U.S. Biopharma Lead

By August 19, 2019May 22nd, 2025No Comments

china-flag-2-pixa

Perhaps the report on China’s strategy for eclipsing the U.S. lead in biopharma from the Information Technology & Innovation Foundation (ITIF) resonated so strongly with me because of several articles in The Wall Street Journal. Taken together, they present a sobering picture of what we’re up against.

{iframe}https://www.ipwatchdog.com/2019/08/15/the-dragon-targets-us-biopharma-lead/id=112230/{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.